This compound is a pharmaceutical intermediate characterized by a triazine ring structure with an amino group and a thioxo group. Its primary significance lies in its use as a building block for the synthesis of other chemical entities.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 33509-43-2
(E)-2-(2-Nitroethenyl)thiophene
pharmaceutical intermediate
2,4-Bis(morpholin-4-yl)-6-chloropyrimidine
pharmaceutical intermediate
N-(3-(2-(2-chloropyrimidin-4-yl)acetyl)-2-fluorophenyl)-2,6-difluorobenzenesulfonamide
pharmaceutical intermediate
4-(5-Bromo-3-chloro-2-pyridinyl)morpholine
pharmaceutical intermediate
1-Bromo-2-butyne
pharmaceutical intermediate
4-Methoxy-N-methyl-2-nitrobenzenamine
pharmaceutical intermediate
(R)-methyl4-((3R,5S,8R,9S,10S,13R,14S,17R)-3-(tert-butyldimethylsilyloxy)-10,13-dimethyl-7-oxo-hexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoate-R28549
pharmaceutical intermediate
Methyl 6-bromo-2-naphthoate
pharmaceutical intermediate
4-amino-6-tert-butyl-3-sulfanylidene-2H-1,2,4-triazin-5-one
OFKAVNQBCRJBJE-UHFFFAOYSA-N
CC(C)(C)C1=NNC(=S)N(C1=O)N
—